echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > BLOOD: Effective treatment of AML with RUNX1 mutation by co-treatment with protein translation inhibitor and bcl2

    BLOOD: Effective treatment of AML with RUNX1 mutation by co-treatment with protein translation inhibitor and bcl2

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com







    Original source:

    Original source:

    Christopher P Mill, Warren Fiskus, Courtney D DiNardo, Christine Birdwell, John A Davis, Tapan Mahendra Kadia, Koichi Takahashi, Nicholas J Short, Naval G.


    Christopher P Mill, Warren Fiskus, Courtney D DiNardo, Christine Birdwell, John A Davis, Tapan Mahendra Kadia, Koichi Takahashi, Nicholas J Short, Naval G.
    Daver, Maro Ohanian, Gautam Borthakur, Steven M Kornblau, Michael R Green, Yuan Qi , Xiaoping Su, Joseph D.
    Khoury, Kapil N Bhalla; Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2.
    Blood Blood2021; blood.
    2021013156.
    doi:https://doi.
    org/ 10.
    1182/blood.
    2021013156

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.